Hikma Pharmaceuticals PLC (LON: HIK)

Hikma Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	205	205	270	426	323	442
Trading Asset Securities	24	24	22	24	24	23
Cash & Short-Term Investments	229	229	292	450	347	465
Cash Growth	-21.58%	-21.58%	-35.11%	29.68%	-25.38%	56.57%
Accounts Receivable	789	789	777	781	662	637
Other Receivables	84	84	64	95	74	110
Total Receivables	873	873	841	876	736	747
Inventory	891	891	776	695	757	568
Prepaid Expenses	72	72	74	65	56	49
Restricted Cash	-	-	-	-	4	1
Other Current Assets	35	35	16	8	22	18
Total Current Assets	2,100	2,100	1,999	2,094	1,922	1,848
Gross Property, Plant & Equipment	2,156	2,156	2,008	1,955	1,841	1,699
Accumulated Depreciation	-1,015	-1,015	-927	-809	-773	-737
Net Property, Plant & Equipment	1,141	1,141	1,081	1,146	1,068	962
Long-Term Investments	65	65	52	46	34	29
Goodwill	388	388	389	285	289	282
Other Intangible Assets	712	712	735	607	587	552
Long-Term Deferred Tax Assets	226	226	192	183	221	243
Other Long-Term Assets	48	48	23	11	14	14
Total Assets	4,680	4,680	4,471	4,372	4,135	3,930
Accounts Payable	309	309	291	262	279	286
Accrued Expenses	388	388	272	305	277	257
Short-Term Debt	46	46	75	64	117	60
Current Portion of Long-Term Debt	104	104	64	48	41	509
Current Portion of Leases	11	11	9	9	10	9
Current Income Taxes Payable	74	74	73	57	72	82
Current Unearned Revenue	179	179	193	213	162	142
Other Current Liabilities	228	228	100	58	70	126
Total Current Liabilities	1,339	1,339	1,077	1,016	1,028	1,471
Long-Term Debt	975	975	1,074	651	692	48
Long-Term Leases	55	55	61	74	72	59
Long-Term Deferred Tax Liabilities	25	25	19	24	31	20
Other Long-Term Liabilities	77	77	92	140	164	203
Total Liabilities	2,471	2,471	2,323	1,905	1,987	1,801
Common Stock	40	40	40	42	41	41
Additional Paid-In Capital	282	282	282	282	282	282
Retained Earnings	2,158	2,158	2,092	2,189	1,892	1,973
Comprensive Income & Other	-282	-282	-279	-60	-80	-178
Total Common Equity	2,198	2,198	2,135	2,453	2,135	2,117
Minority Interest	11	11	13	14	13	12
Shareholders' Equity	2,209	2,209	2,148	2,467	2,148	2,129
Total Liabilities & Equity	4,680	4,680	4,471	4,372	4,135	3,930
Total Debt	1,191	1,191	1,283	846	932	685
Net Cash (Debt)	-962	-962	-991	-396	-585	-220
Net Cash Per Share	-4.33	-4.33	-4.41	-1.70	-2.46	-0.91
Filing Date Shares Outstanding	221.08	221.08	220.24	231.5	230.46	242.28
Total Common Shares Outstanding	221.08	221.08	220.24	231.5	230.46	242.28
Working Capital	761	761	922	1,078	894	377
Book Value Per Share	9.94	9.94	9.69	10.60	9.26	8.74
Tangible Book Value	1,098	1,098	1,011	1,561	1,259	1,283
Tangible Book Value Per Share	4.97	4.97	4.59	6.74	5.46	5.30
Land	797	797	725	676	636	597
Machinery	1,042	1,042	964	934	891	810
Construction In Progress	272	272	262	271	255	233

Source: S&P Capital IQ. Standard template.